Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
about
An integrative view on sex differences in brain tumorsInterdisciplinary networks for the treatment of childhood pulmonary vascular disease: what pulmonary hypertension doctors can learn from pediatric oncologistsBalancing high accrual and ethical recruitment in paediatric oncology: a qualitative study of the 'look and feel' of clinical trial discussions.Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors.Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review.Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.Treatment of acute leukemia in children: recent advances and future challenges.The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemiaThe best way to use asparaginase in childhood acute lymphatic leukaemia--still to be defined?Evidence for under-diagnosis of childhood acute lymphoblastic leukaemia in poorer communities within Great Britain.Quantitative analysis of minimal residual disease predicts relapse in children with B-lineage acute lymphoblastic leukemia in DFCI ALL Consortium Protocol 95-01.Leukemic infiltration of the orbit: report of three cases and literature review.Gender differences in cancer susceptibility: an inadequately addressed issue.Survival following relapse in childhood haematological malignancies diagnosed in 1974-2003 in Yorkshire, UKChildhood leukaemia: long-term excess mortality and the proportion 'cured'.Acute leukemia as a secondary malignancy in children and adolescents: current findings and issues.Analysis of outcomes and prognostic factors of acute lymphoblastic leukemia patients treated by MCP841 protocol: A regional cancer center experience.Excellent outcome of minimal residual disease-defined low-risk patients is sustained with more than 10 years follow-up: results of UK paediatric acute lymphoblastic leukaemia trials 1997-2003.Recruitment of childhood leukaemia patients to clinical trials in Great Britain during 1980-2007: variation by birth weight, congenital malformation, socioeconomic status and ethnicity.New cellular markers at diagnosis are associated with isolated central nervous system relapse in paediatric B-cell precursor acute lymphoblastic leukaemia.Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia.Childhood acute lymphoblastic leukemia.Remission of severe, intractable autoimmune haemolytic anaemia following matched unrelated donor transplantation.The contribution of randomized trials to the cure of haematological disorders from Bradford Hill onwards.The Eighth International Childhood Acute Lymphoblastic Leukemia Workshop ('Ponte di legno meeting') report: Vienna, Austria, April 27-28, 2005.Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran.Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome
P2860
Q26829861-B2904D57-1159-4CBF-89C4-030EB981CDEEQ26860314-3C7D9D50-4F13-4CB8-9969-3996C225C3F2Q30497244-A3E46DF1-DB37-4DF2-8751-E86607CB20C1Q33647139-05AB0963-31AC-449C-A136-E98829770618Q34097044-042497D4-D108-45ED-B5E4-BB2CBF5D1259Q34448334-B696E5FC-B190-4C7E-980F-DB348AA1CE83Q34532636-A99882B0-DE1B-4500-9EBA-0B7155BF76E8Q34734242-E338D168-6FF3-4418-A33A-81417D9C7DBDQ35094049-16313C8F-0785-48B2-A6A4-90D2CF72C863Q35732108-6E0D5B39-2E9A-42DD-822E-CF66B5E6E8FDQ35927146-C96AD1F6-5649-4EA4-9B12-0A458BA90D18Q35989461-5D7C46F6-2B54-44A5-B012-040D4A7E60DBQ36195161-0270AF1A-5DC2-45D2-8F0E-484EB58B76EDQ36429270-8759FDC4-2938-41EC-87F5-7A11EFFB5A2BQ36610199-1BC45107-0391-40EF-9692-C005295C6BE5Q36755145-4A04B3D0-572F-43C6-BF6B-1B33155DC6B1Q37346340-1FDCB2E2-1465-41EA-868C-DAE5DEEDA24CQ37436345-8D8F0376-0BCB-4C7C-94B5-5FB56A3CA190Q38909642-2147440E-081C-4707-BF8D-9BDBC0EDB323Q39234466-86ED7DFE-62FD-4662-9BEB-4EBE48AABAAAQ39981524-5E9C9DF7-811E-45C7-BCC6-F3EDDFC171D9Q40621159-71D968E7-1356-430D-B3FD-83FCD50DAC0FQ40637650-9AE49E57-1546-46C6-AC43-179723D8ADCFQ43848107-0F92624F-5C9E-494D-851B-B77C48E797CCQ44231445-9D24CE65-2A0D-4442-A085-68B57D14FC90Q44627350-E49BC838-11F4-463C-B725-AB15D63CE4BFQ46543487-083B1B7E-E764-4882-B237-E3A11BB46949Q55120372-5C3BB3CB-794C-4B51-9CC2-9FB9D3E02E01Q58481881-0FCADAF3-0EE2-4432-8453-54C22B40DFDC
P2860
Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Long-term follow-up of the Uni ...... dhood Leukaemia Working Party.
@en
Long-term follow-up of the Uni ...... dhood Leukaemia Working Party.
@nl
type
label
Long-term follow-up of the Uni ...... dhood Leukaemia Working Party.
@en
Long-term follow-up of the Uni ...... dhood Leukaemia Working Party.
@nl
prefLabel
Long-term follow-up of the Uni ...... dhood Leukaemia Working Party.
@en
Long-term follow-up of the Uni ...... dhood Leukaemia Working Party.
@nl
P2093
P356
P1433
P1476
Long-term follow-up of the Uni ...... dhood Leukaemia Working Party.
@en
P2093
Chessells JM
Harrison G
Lilleyman JS
Richards S
P2888
P304
P356
10.1038/SJ.LEU.2401962
P577
2000-12-01T00:00:00Z